Kamada (KMDA) Net Margin Growth (1y) (2013 - 2026)
Kamada (KMDA) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 473.85 Mn | 444.38 Mn | 22.47 Mn | 38.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -453.00 |
| Mar 31, 2026 | -634.00 |
| Dec 31, 2025 | 1,037.00 |
| Sep 30, 2025 | 616.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 1,438.00 |
| Dec 31, 2024 | -1,085.00 |
| Sep 30, 2024 | 116.00 |
| Jun 30, 2024 | -484.00 |
| Mar 31, 2024 | 666.00 |
| Dec 31, 2023 | 655.00 |
| Sep 30, 2023 | 850.00 |
| Jun 30, 2023 | -1,189.00 |
| Mar 31, 2023 | -651.00 |
| Dec 31, 2022 | 2,246.00 |
| Sep 30, 2022 | -377.00 |
| Jun 30, 2022 | 1,275.00 |
| Mar 31, 2022 | -428.00 |
| Dec 31, 2021 | -2,048.00 |
| Sep 30, 2021 | -1,558.00 |